Decoy Therapeutics Financials - Benzinga

Decoy Therapeutics Inc

DCOYNASDAQ

Trade with Public

Trade with Public

$3.10

0.5421.09%

가까이에: Sep 21, 5:00 PM EST

$5.13

2.57100.47%

프리마켓: 7:07 AM EST

PRO

변동 이유?:Decoy Therapeutics shares are trading higher after the company announced a ...

개요 뉴스 실적 전망 이벤트 목표가재무심리 비교 주식 보고서

Decoy Therapeutics Financials

Decoy Therapeutics (DCOY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved